Specialty-drug appeal support

Turn your drug denial into a real appeal.

DoseBridge helps patients challenge GLP-1 and specialty-medication denials with insurer-specific documentation, organized submissions, and deadline tracking.

No upfront appeal fee. We only charge the success fee if coverage is won.

DoseBridge hero

Our standard

Clear terms. Careful work. No false promises.

Honest assessment

We review the denial and coverage criteria before recommending a paid path forward.

Patient control

You approve submissions, understand the timeline, and can see what information is being used.

Outcome-aligned

The core appeal starts at $0 upfront. A fee applies only when the appeal secures coverage.

Built for the paperwork gap

We translate a denial into a documented case.

DoseBridge focuses on the administrative details that often determine whether a medically supported prescription reaches the right reviewer.

  1. 01

    Decode the denial

    We identify the cited reason, appeal route, deadline, plan requirements, and missing evidence. You get a plain-language assessment before work begins.

  2. 02

    Build the record

    We coordinate the relevant records and structure the appeal around insurer-specific criteria, prior therapies, clinical context, and the denial language.

  3. 03

    Submit and follow through

    We prepare the submission, track the response window, and organize next steps if the plan requests more information or another review level is available.

One focused starting point

GLP-1 denials first. Other specialty medications next.

A narrow focus lets us learn plan criteria deeply instead of offering generic billing advice. Where appropriate, the same structured approach can support other recurring specialty-drug denials.

$0

upfront for an eligible appeal

Eligibility, fees, and scope are confirmed in writing before you authorize work.

Pricing

Pay for progress, not paperwork.

Choose a one-time appeal or ongoing coverage monitoring. Exact success fees are agreed before engagement and depend on the annualized value of coverage.

Appeal support

$0 upfront

15–20% of the first year’s estimated covered value, charged only after a successful appeal.

  • ✓ Denial and deadline review
  • ✓ Plan-criteria research
  • ✓ Documentation checklist
  • ✓ Appeal preparation and tracking

Coverage Guardian

$19/month

Ongoing support for patients maintaining coverage on a recurring specialty medication.

  • ✓ Reauthorization reminders
  • ✓ Formulary change monitoring
  • ✓ Updated document checklist
  • ✓ Refiling coordination

DoseBridge does not provide medical or legal advice and cannot guarantee an insurer’s decision. Your clinician remains responsible for clinical decisions and prescriptions.

A denial is a decision—not the last word

Bring us the letter. We’ll map the next move.

Review my options